This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold on to Envestnet (ENV) Stock For Now
by Zacks Equity Research
Envestnet's (ENV) business model ensures solid asset-based and subscription-based recurring revenue generation capacity.
Here's Why You Should Buy FLEETCOR Technologies (FLT) Stock Now
by Zacks Equity Research
FLEETCOR's (FLT) top line continues to grow organically, driven by an increase in transaction volume and acquisitions.
Cross Country Healthcare (CCRN) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Omnicom (OMC) to Buy Berlin-Based Advertising Agency, antoni
by Zacks Equity Research
The acquisition is aimed at placing antoni in a pivotal role in Omnicom's (OMC) partnership with Mercedes-Benz to develop Team X.
Omnicom (OMC) to Acquire German Public Relations Agency OSK
by Zacks Equity Research
OSK, which serves Mercedes-Benz, can play a vital role in Omnicom's (OMC) partnership with the automotive luxury brand to develop Team X.
Here's Why You Should Retain Broadridge (BR) in Your Portfolio
by Zacks Equity Research
Solid shareholder-friendly measures and strong business model boosts Broadridge (BR) stock.
Here's Why You Should Retain Omnicom (OMC) Stock For Now
by Zacks Equity Research
Omnicom (OMC) focuses on investing in real estate, back-office services, procurement and IT.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
WEX's revenue stability is being aided by its product and service quality, as well as its deep understanding of customers' operational needs.
4 Small-Cap ETFs & Stocks to Explode Higher
by Sweta Killa
With renewed optimism over a sustained economic recovery and robust corporate earnings growth, the small-cap space is set to explode higher.
Is Cross Country Healthcare (CCRN) Stock a Solid Choice Right Now?
by Zacks Equity Research
Cross Country Healthcare (CCRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's Why Cross Country Healthcare (CCRN) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Cross Country Healthcare (CCRN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Accenture (ACN) Arm Hires Data Strategy Expert for Defense
by Zacks Equity Research
Dr. Crowe will help implement artificial intelligence and machine learning based transformation strategies for Accenture's (ACN) federal clients.
Accenture (ACN) Invests in ixlayer to Boost Virtual Healthcare
by Zacks Equity Research
Accenture (ACN) aims at utilizing ixlayer's innovative solutions to respond to the growing demand for virtual healthcare facilities amid the pandemic.
Equifax (EFX) Up on Buyouts and Innovation, Debt Woe Stays
by Zacks Equity Research
Equifax (EFX) serves a wide range of industries and has a diversified client base.
Booz Allen (BAH) Up on Transformation Moves, Debt Woe Stays
by Zacks Equity Research
Booz Allen (BAH) has developed its solutions business in a way that it creates differentiated business models and sales channels, and increases client acquisition.
Zacks.com featured highlights include: Macy's, CONSOL Energy, Cross Country Healthcare, Bloomin' Brands and Builders FirstSource
by Zacks Equity Research
Zacks.com featured highlights include: Macy's, CONSOL Energy, Cross Country Healthcare, Bloomin' Brands and Builders FirstSource
5 Broker-Friendly Stocks to Foil Delta Variant & Other Scares
by Maharathi Basu
Stocks like Macy''s (M), CONSOL Energy (CEIX), Cross Country Healthcare (CCRN), Bloomin Brands (BLMN) and Builders FirstSource (BLDR) should be on an investor's radar owing to recent upgrade by brokers.
The Zacks Analyst Blog Highlights: Heidrick & Struggles, Cross Country Healthcare, ManpowerGroup and Korn Ferry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Heidrick & Struggles, Cross Country Healthcare, ManpowerGroup and Korn Ferry
Reasons to Hold Trane Technologies (TT) Stock in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) prioritizes improving its business operating system and innovation through transformation initiatives and investments.
Rapid Reopening Drives Employment: 4 Staffing Stocks to Buy
by Ritujay Ghosh
With more job openings, hiring is expected to rise further in the United States. This thus makes for an ideal opportunity to invest in staffing stocks HSII, CCRN, MAN and KFY.
Reasons to Hold DocuSign (DOCU) Stock in Your Portfolio
by Zacks Equity Research
DocuSign (DOCU) remains focused on continuously acquiring eSignature customers and expanding internationally.
Can Cross Country (CCRN) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks.com featured highlights include: Cross Country Healthcare, Greenbrier, AutoNation, Peabody Energy and Bloomin' Brands
by Zacks Equity Research
Zacks.com featured highlights include: Cross Country Healthcare, Greenbrier, AutoNation, Peabody Energy and Bloomin' Brands
Recent Upgrade by Brokers Leads These 5 Stocks to Fly High
by Maharathi Basu
Investors should watch out for broker-friendly stocks like Cross Country Healthcare (CCRN), Greenbrier (GBX), Peabody Energy (BTU), AutoNation (AN) and Bloomin Brands (BLMN) as they strive for higher returns.
5 Staffing Stocks to Buy on July's Impressive Jobs Report
by Ritujay Ghosh
Hiring is picking up at record pace, which is likely to benefit staffing companies like KornFerry International (KFY), Cross Country Healthcare, (CCRN) and Heidrick & Struggles International (HSII)